The seesaw oscillations of influenza and COVID-19 in China: 2022-2023

Yan Yang; Lina Geng; Lirong Huang; Chenli Ding; Linlin Yu; Zheng Xue

doi:10.4103/apjtm.apjtm_250_24

Asian Pacific Journal of Tropical Medicine ›› 2024, Vol. 17 ›› Issue (12) :568 -570. DOI: 10.4103/apjtm.apjtm_250_24

Letter to Editor

research-article

The seesaw oscillations of influenza and COVID-19 in China: 2022-2023

Author information +

History +

PDF (230KB)

Cite this article

Download citation ▾

Yan Yang, Lina Geng, Lirong Huang, Chenli Ding, Linlin Yu, Zheng Xue. The seesaw oscillations of influenza and COVID-19 in China: 2022-2023. Asian Pacific Journal of Tropical Medicine, 2024, 17 (12) : 568-570 DOI:10.4103/apjtm.apjtm_250_24

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: A modelling study. Lancet 2018; 391(10127): 1285-1300.

[2]	Gong H, Shen X, Yan H, Lu WY, Zhong GJ, Dong KG, et al. Estimating the disease burden of seasonal influenza in China, 2006-2019. Zhonghua Yi Xue Za Zhi 2021; 101(8): 560-567.

[3]	Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now 2021; 51(5): 418-423.

[4]	Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression. Lancet 2022; 399(10328): 924-944.

[5]	Zhao HT, Peng ZB, Ni ZL, Yang XK, Guo QY, Zheng JD, et al. Investigation on influenza vaccination policy and vaccination situation during the influenza seasons of 2020-2021 and 2021-2022 in China. Chin J Prev Med 2022; 56(11): 1560-1564.

[6]	Vogel OA, Manicassamy B. Broadly protective strategies against influenza viruses: Universal vaccines and therapeutics. Front Microbiol 2020; 11: 135.

[7]	Oishi K, Horiuchi S, Minkoff JM, TenOever BR. The host response to influenza A virus interferes with SARS-CoV-2 replication during coinfection. J Virol 2022; 96(15): e0076522.

[8]	Rodrigues TS, de Sá KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med 2021; 218(3): e20201707.

[9]	Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann Am Thorac Soc 2015; 12: S150-S156.

[10]	Chu XJ, Song DD, Zhou MH, Chen XZ, Chu N, Li M, et al. Perturbations in gut and respiratory microbiota in COVID-19 and influenza patients: A systematic review and meta-analysis. Front Med (Lausanne) 2024; 11: 1301312.